<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03220958</url>
  </required_header>
  <id_info>
    <org_study_id>2017-7898</org_study_id>
    <nct_id>NCT03220958</nct_id>
  </id_info>
  <brief_title>Metoclopramide for Post Traumatic Headache</brief_title>
  <official_title>A Randomized Placebo Controlled Trial of IV Metoclopramide for Acute Post-traumatic Headache</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nearly 1.5 million patients present to US emergency departments annually following head
      trauma. Headache is a frequent symptom of victims of head trauma. The purpose of this study
      is to see if an intravenous medication called metoclopramide can improve the symptoms of
      patients with acute post-traumatic headache.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numerical rating scale for pain</measure>
    <time_frame>1 hour after medication administration</time_frame>
    <description>Improvement in this 0 to 10 verbal rating scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sustained headache relief</measure>
    <time_frame>48 hours after medication administration</time_frame>
    <description>Achieving a headache intensity of mild or none in the ED without use of rescue medication and maintaining a level of mild or none.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Headache days</measure>
    <time_frame>7 days after ED visit</time_frame>
    <description>Number of days with any headache</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Sport Concussion Assessment Tool (SCAT) Post Concussion Symptom Scale (PCSS).</measure>
    <time_frame>48 hours, 7 days, and 1 month</time_frame>
    <description>On this validated instrument, patients rate 25 symptoms on a 0 to 6 scale.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">162</enrollment>
  <condition>Post-Traumatic Headache</condition>
  <arm_group>
    <arm_group_label>Metoclopramide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Metoclopramide 20mg + diphenhydramine 25mg + 100cc normal saline, administered as an intravenous drip</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline, administered as an intravenous drip</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metoclopramide</intervention_name>
    <description>Metoclopramide 20mg</description>
    <arm_group_label>Metoclopramide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diphenhydramine</intervention_name>
    <description>Diphenhydramine 25mg</description>
    <arm_group_label>Metoclopramide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>100ml normal saline</description>
    <arm_group_label>Metoclopramide</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Included patients will be adults who meet International Classification of Headache
        Disorders criteria for acute post-traumatic headache. These are as follows:

          -  Traumatic injury to the head has occurred

          -  Headache has developed within 7 days of injury to the head

          -  Headache is not better accounted for by another diagnosis (eg, previous history of
             migraine or tension-type headache)

        The headache must be rated as moderate or severe in intensity at the time of initial
        evaluation.

        Exclusion Criteria:

        Patients will be excluded if more than ten days have elapsed since the head trauma, if the
        headache has already been treated with an anti-dopaminergic medication, or for medication
        contra-indications including pheochromocytoma, seizure disorder, Parkinson's disease, use
        of MAO inhibitors, and use of anti-rejection transplant medications.
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Benjamin W Friedman, MD, MS</last_name>
    <phone>718-920-6626</phone>
    <email>befriedm@montefiore.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Benjamin W Friedman</last_name>
    <phone>718-920-6626</phone>
    <email>befriedm@montefiore.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin W Friedman, MD, MS</last_name>
      <phone>718-920-6626</phone>
      <email>befriedm@montefiore.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 19, 2017</study_first_submitted>
  <study_first_submitted_qc>July 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 18, 2017</study_first_posted>
  <last_update_submitted>April 15, 2018</last_update_submitted>
  <last_update_submitted_qc>April 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montefiore Medical Center</investigator_affiliation>
    <investigator_full_name>Benjamin W. Friedman, MD</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache</mesh_term>
    <mesh_term>Post-Traumatic Headache</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diphenhydramine</mesh_term>
    <mesh_term>Metoclopramide</mesh_term>
    <mesh_term>Promethazine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

